Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43

Clinical trial NCT01563263 · COMPLETED

Trial details

NCT number: NCT01563263
Sponsor: Valneva Austria GmbH
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pseudomonas Aeruginosa Infection

Start date: 2012-03-01
Primary completion: 2015-08-01
Enrollment: 803

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.